Identification and validation of interferon-stimulated gene 15 as a biomarker for dermatomyositis by integrated bioinformatics analysis and machine learning.

Journal: Frontiers in immunology
PMID:

Abstract

BACKGROUND: Dermatomyositis (DM) is an autoimmune disease that primarily affects the skin and muscles. It can lead to increased mortality, particularly when patients develop associated malignancies or experience fatal complications such as pulmonary fibrosis. Identifying reliable biomarkers is essential for the early diagnosis and treatment of DM. This study aims to identify and validate pivotal diagnostic biomarker for DM through integrated bioinformatics analysis and clinical sample validation.

Authors

  • Xingwang Wang
    Department of Dermatology, General Hospital of Southern Theater Command, Guangzhou, China.
  • Hao Hu
    Department of Geography and Geographic Information Science, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
  • Guangning Yan
    Department of Pathology, General Hospital of Southern Theater Command, Guangzhou, China.
  • Bo Zheng
    State Key Joint Laboratory of Environment Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing 100084, China.
  • Jinxia Luo
    Department of Pathology, General Hospital of Southern Theater Command, Guangzhou, China.
  • Jianyong Fan
    Department of Dermatology, General Hospital of Southern Theater Command, Guangzhou, China.